acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 09 Feb 2022 Acarix lämnar in ansökan om status som Breakthrough Therapy till FDA vid diagnosen hjärtsvikt Pressmeddelande Malmö, 9 februari 2022 Acarix lämnar in ansökan om status som Breakthrough Therapy til... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 09 Feb 2022 Acarix submits breakthrough designation request with FDA for heart failure diagnosis Press release Malmö, Sweden, February 9, 2022 Acarix submits breakthrough designation request with FDA for heart... Continue reading
acarix Corporate Information, Financial calendar, IR, Listing Regulation, News, Regulatory, Swedish November 18, 2024 09 Feb 2022 Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjärde kvartalet till den 17 februari 2022 PressmeddelandeMalmö, 9 februari, 2022 Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjär... Continue reading
acarix Corporate Information, English, Financial calendar, IR, Listing Regulation, News, Regulatory November 18, 2024 09 Feb 2022 Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022 Press release Malmö, Sweden, February 9, 2022 Acarix AB (publ) brings forward publication of interim report for ... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 07 Feb 2022 Acarix invites to virtual Capital Market Day Press releaseMalmö, Sweden, February 7, 2022 Acarix invites to virtual Capital Market Day Acarix is stepping up commercializa... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 07 Feb 2022 Acarix bjuder in till virtuell kapitalmarknadsdag Press release Malmö, 7 februari, 2022 Acarix bjuder in till virtuell kapitalmarknadsdag Acarix, noterat på Nasdaq First ... Continue reading
acarix Corporate Information, English, IR, MAR, News, Regulatory, Staff change November 18, 2024 10 Jan 2022 Acarix appoints US based Helen Ljungdahl Round as new CEO Press release (MAR)Malmö, Sweden, January 10, 2022 Acarix appoints US based Helen Ljungdahl Round as new CEO The Board of Acarix... Continue reading
acarix Corporate Information, IR, MAR, News, Regulatory, Staff change, Swedish November 18, 2024 10 Jan 2022 Acarix utser USA-baserade Helen Ljungdahl Round till ny VD Press release (MAR)Malmö, 10 januari, 2022 Acarix utser USA-baserade Helen Ljungdahl Round till ny VD Styrelsen för Acarix ... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish November 18, 2024 23 Nov 2021 Kommuniké från extra bolagsstämma i Acarix Press release Malmö, 23 november, 2021 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i A... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 23 Nov 2021 Announcement from Acarix’s extra general meeting Press release Malmö, November 23, 2021 Announcement from Acarix's extra general meeting The extra general meeting of Acarix AB (... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 09 Nov 2021 Acarix accelerates US market entry with Proximo Medical as commercialization partner Press release (MAR)Malmö, Sweden, November 9, 2021 Acarix accelerates US market entry with Proximo Medical as commerciali... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 08 Nov 2021 Acarix US expansion to be a major contributor to the company’s new financial and operational goals Press release (MAR)Malmö, Sweden, November 8, 2021 Acarix US expansion to be a major contributor to the company’s new fina... Continue reading